Literature DB >> 9822726

Ca2+/calcineurin-inhibited adenylyl cyclase, highly abundant in forebrain regions, is important for learning and memory.

F A Antoni1, M Palkovits, J Simpson, S M Smith, A L Leitch, R Rosie, G Fink, J M Paterson.   

Abstract

Activation of cAMP synthesis by intracellular Ca2+ is thought to be the main mode of cAMP generation in the brain. Accordingly, the Ca2+-activated adenylyl cyclases I and VIII are expressed prominently in forebrain neurons. The present study shows that the novel adenylyl cyclase type IX is inhibited by Ca2+ and that this effect is blocked selectively by inhibitors of calcineurin such as FK506 and cyclosporin A. Moreover, adenylyl cyclase IX is inhibited by the same range of intracellular free Ca2+ concentrations that stimulate adenylyl cyclase I. Adenylyl cyclase IX is expressed prominently in the forebrain. Substantial arrays of neurons positive for AC9 mRNA were found in the olfactory lobe, in limbic and neocortical areas, in the striatum, and in the cerebellar system. These data show that the initiation of the cAMP signal by adenylyl cyclase may be controlled by Ca2+/calcineurin and thus provide evidence for a novel mode of tuning the cAMP signal by protein phosphorylation/dephosphorylation cascades.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9822726      PMCID: PMC6793314     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  61 in total

Review 1.  Immunophilin-sensitive protein phosphatase action in cell signaling pathways.

Authors:  S L Schreiber
Journal:  Cell       Date:  1992-08-07       Impact factor: 41.582

2.  Distinct cellular expression of calcineurin A alpha and A beta in rat brain.

Authors:  T Kuno; H Mukai; A Ito; C D Chang; K Kishima; N Saito; C Tanaka
Journal:  J Neurochem       Date:  1992-05       Impact factor: 5.372

3.  Superoxide dismutase protects calcineurin from inactivation.

Authors:  X Wang; V C Culotta; C B Klee
Journal:  Nature       Date:  1996-10-03       Impact factor: 49.962

4.  Adenylyl cyclase amino acid sequence: possible channel- or transporter-like structure.

Authors:  J Krupinski; F Coussen; H A Bakalyar; W J Tang; P G Feinstein; K Orth; C Slaughter; R R Reed; A G Gilman
Journal:  Science       Date:  1989-06-30       Impact factor: 47.728

Review 5.  Adaptation in cyclic AMP signalling processes: a central role for cyclic AMP phosphodiesterases.

Authors:  M D Houslay
Journal:  Semin Cell Dev Biol       Date:  1998-04       Impact factor: 7.727

6.  Restricted and regulated overexpression reveals calcineurin as a key component in the transition from short-term to long-term memory.

Authors:  I M Mansuy; M Mayford; B Jacob; E R Kandel; M E Bach
Journal:  Cell       Date:  1998-01-09       Impact factor: 41.582

7.  Synergistic activation of the type I adenylyl cyclase by Ca2+ and Gs-coupled receptors in vivo.

Authors:  G A Wayman; S Impey; Z Wu; W Kindsvogel; L Prichard; D R Storm
Journal:  J Biol Chem       Date:  1994-10-14       Impact factor: 5.157

8.  Heparin-insensitive calcium release from intracellular stores triggered by the recombinant human parathyroid hormone receptor.

Authors:  K Seuwen; H G Boddeke
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

9.  Measurement of Calcineurin Phosphatase Activity in Cell Extracts

Authors: 
Journal:  Methods       Date:  1996-04       Impact factor: 3.608

10.  Calcineurin feedback inhibition of agonist-evoked cAMP formation.

Authors:  F A Antoni; R J Barnard; M J Shipston; S M Smith; J Simpson; J M Paterson
Journal:  J Biol Chem       Date:  1995-11-24       Impact factor: 5.157

View more
  28 in total

1.  Differential activation of adenylyl cyclases by spatial and procedural learning.

Authors:  J L Guillou; G M Rose; D M Cooper
Journal:  J Neurosci       Date:  1999-07-15       Impact factor: 6.167

2.  A common signaling pathway for striatal NMDA and adenosine A2a receptors: implications for the treatment of Parkinson's disease.

Authors:  J E Nash; J M Brotchie
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

3.  Impaired D2 dopamine receptor function in mice lacking type 5 adenylyl cyclase.

Authors:  Ko-Woon Lee; Jang-Hee Hong; In Young Choi; Yongzhe Che; Ja-Kyeong Lee; Sung-Don Yang; Chang-Woo Song; Ho Sung Kang; Jae-Heun Lee; Jai Sung Noh; Hee-Sup Shin; Pyung-Lim Han
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

4.  Type 7 adenylyl cyclase-mediated hypothalamic-pituitary-adrenal axis responsiveness: influence of ethanol and sex.

Authors:  Sergey P Pronko; Laura M Saba; Paula L Hoffman; Boris Tabakoff
Journal:  J Pharmacol Exp Ther       Date:  2010-04-02       Impact factor: 4.030

Review 5.  Nanometric targeting of type 9 adenylyl cyclase in heart.

Authors:  Autumn N Marsden; Carmen W Dessauer
Journal:  Biochem Soc Trans       Date:  2019-12-20       Impact factor: 5.407

6.  Cellular localisation of adenylyl cyclase: a post-genome perspective.

Authors:  Ferenc A Antoni; Ulrich K Wiegand; Jamie Black; James Simpson
Journal:  Neurochem Res       Date:  2006-02       Impact factor: 3.996

Review 7.  Regulation and organization of adenylyl cyclases and cAMP.

Authors:  Dermot M F Cooper
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

Review 8.  Evolutionary conservation of the signaling proteins upstream of cyclic AMP-dependent kinase and protein kinase C in gastropod mollusks.

Authors:  Wayne S Sossin; Thomas W Abrams
Journal:  Brain Behav Evol       Date:  2009-12-21       Impact factor: 1.808

9.  Direct stimulation of adenylyl cyclase 9 by the fungicide imidazole miconazole.

Authors:  James Simpson; Adrienn Pálvölgyi; Ferenc A Antoni
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-01-03       Impact factor: 3.000

10.  Dex-ras1 and serum- and glucocorticoid-inducible protein kinase 1: regulation of expression by dexamethasone in HEK293 cells.

Authors:  Ghassem Attarzadeh-Yazdi; Michael J Shipston; Ferenc A Antoni
Journal:  Neurochem Res       Date:  2007-11-06       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.